Unicycive Therapeutics Inc (UNCY) stock news · $195.0M cap
Unicycive Therapeutics Inc (UNCY) is a biotechnology company listed on NASDAQ.
This UNCY news page leads with what Unicycive Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for UNCY yet. We will not pad this page with generic market recap.
Latest reported UNCY revenue for 2023-09-30 was $675.0K. Net income was -$4.3M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. UNCY currently screens at market cap $195.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the UNCY stock page; for the tape open the quote page.
UNCY stock news FAQ
What are UNCY's latest revenue and net income?
Latest cached Unicycive Therapeutics Inc (UNCY) revenue for Sep 30, 2023 was $675.0K. Net income was -$4.3M. Statements: https://lician.com/financials/uncy
How did UNCY revenue change from the prior cached period?
Cached Unicycive Therapeutics Inc (UNCY) revenue was unchanged from $675.0K (Jun 30, 2023) to $675.0K (Sep 30, 2023). Statements: https://lician.com/financials/uncy
What is UNCY's market cap?
Unicycive Therapeutics Inc (UNCY) market cap is $195.0M on the latest cached fundamentals snapshot.
What kind of company is UNCY?
Unicycive Therapeutics Inc (UNCY) is a biotechnology company listed on NASDAQ.
Where is UNCY stock news listed?
Cached stock news for Unicycive Therapeutics Inc (UNCY) is listed at https://lician.com/news/uncy. Filings: https://lician.com/sec/uncy
Not investment advice.